Open Access 01-01-2022 | Famotidine | Correspondence
No Evidence Indicates Famotidine Reduces the Risk of Serious Disease in COVID-19 Patients After Propensity Score Matching: Meta-Analysis and Systematic Reviews
Published in: Digestive Diseases and Sciences | Issue 1/2022
Login to get access